Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mikkael A Sekeres
Glasdegib Plus Intensive/Nonintensive Chemotherapy in Untreated Acute Myeloid Leukemia: BRIGHT AML 1019 Phase III Trials
Future Oncology
Medicine
Cancer Research
Oncology
Related publications
Secondary Acute Myeloid Leukemia (sAML) Immediately After Intensive Chemotherapy of Acute Lymphoblastic Leukemia (ALL)
Journal of Leukemia
Immunologic Consequences of Chemotherapy for Acute Myeloid Leukemia
Journal of Pediatric Hematology/Oncology
Child Health
Oncology
Pediatrics
Hematology
Perinatology
Cost-Effectiveness Analysis of Midostaurin (MIDO) With Standard Chemotherapy (SOC) for Acute Myeloid Leukemia (AML) in the United Kingdom (UK)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Acute Myeloid Leukemia
JAMA - Journal of the American Medical Association
Medicine
Acute Myeloid Leukemia
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Pediatric Acute Myeloid Leukemia (AML): From Genes to Models Toward Targeted Therapeutic Intervention
Frontiers in Pediatrics
Child Health
Pediatrics
Perinatology
The Clinical Relevance of Cellular Drug Resistance Testing in Childhood Acute Myeloid Leukemia (AML)
Pediatric Research
Child Health
Pediatrics
Perinatology
Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia
Clinical Hematology International
Analysis of Transplantation Rate and Overall Treatment Efficacy by Age for Patients Aged 60 to 75 With Untreated Secondary Acute Myeloid Leukemia (AML) Given CPX-351 Liposome Injection Versus Conventional Cytarabine and Daunorubicin in a Phase III Trial
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
